Search results for " Sepsi"

showing 10 items of 80 documents

New diagnostic possibilities in systemic neonatal infections: metabolomics

2014

Systemic neonatal infection is a serious complication in preterm and term infants and is defined as a complex clinical syndrome caused by bacteria, fungi and virus. Sepsis remains among the leading causes of death in both developed and underdeveloped countries above all in the neonatal period. Earlier diagnosis may offer the ability to initiate treatment to prevent adverse outcomes. There have been many studies on various diagnostic haematological markers like acute phase reactants, C-reactive protein, procalcitonin, interleukins and presepsin. However, there is still no single test that satisfies the criteria as being the ideal marker for the early diagnosis of neonatal sepsis. In this reg…

medicine.medical_specialtyNeonatal infections; metabolomicsNeonatal sepsisbusiness.industryAcute-phase proteinInfant NewbornObstetrics and Gynecologymedicine.diseaseProcalcitoninSingle testSepsisNeonatal infectionMetabolomicsSettore MED/38 - Pediatria Generale E SpecialisticaSepsisPediatrics Perinatology and Child HealthmedicineHumansMetabolomicsbusinessIntensive care medicineComplicationNeonatal infectionBiomarkers
researchProduct

Antimicrobial therapy in neonatal intensive care unit

2015

Severe infections represent the main cause of neonatal mortality accounting for more than one million neonatal deaths worldwide every year. Antibiotics are the most commonly prescribed medications in neonatal intensive care units (NICUs) and in industrialized countries about 1% of neonates are exposed to antibiotic therapy. Sepsis has often nonspecific signs and symptoms and empiric antimicrobial therapy is promptly initiated in high risk of sepsis or symptomatic infants. However continued use of empiric broad-spectrum antibiotic treatment in the setting of negative cultures especially in preterm infants may not be harmless. The benefits of antibiotic therapy when indicated are clearly enor…

medicine.medical_specialtyNeonatal intensive care unitmedicine.drug_classAntibioticsReviewGlobal HealthInfant Newborn DiseasesSepsisIntensive Care Units NeonatalIntensive caremedicineHumansAntibiotic prophylaxisAdverse effectIntensive care medicineEmpiric therapyAntibiotic stewardshipNeonatal sepsisbusiness.industryInfant NewbornAntibioticAntibiotic ProphylaxisNewbornmedicine.diseaseAnti-Bacterial AgentsAntibiotic; Antibiotic stewardship; Empiric therapy; Neonatal sepsis; Newborn; Resistant bacteria; Pediatrics Perinatology and Child HealthPediatrics Perinatology and Child HealthNeonatal sepsisNeonatal sepsiResistant bacteriabusinessEmpiric therapyItalian Journal of Pediatrics
researchProduct

Higher levels of IgA and IgG at sepsis onset are associated with higher mortality: results from the Albumin Italian Outcome Sepsis (ALBIOS) trial

2021

Abstract Background The role of intravenous immunoglobulins (IVIG) during sepsis is controversial, as different trials on IVIG have observed inconsistent survival benefits. We aimed to elucidate the possible association and clinical significance between circulating levels of immunoglobulins. Methods In a subset of 956 patients with severe sepsis and septic shock of the multicentre, open-label RCT ALBIOS, venous blood samples were serially collected 1, 2, and 7 days after enrolment (or at ICU discharge, whichever came first). IgA, IgG and IgM concentrations were assayed in all patients on day 1 and in a subgroup of 150 patients on days 2 and 7. Ig concentrations were measured employing a tur…

medicine.medical_specialtySepsiIgGSecondary infectionCritical Care and Intensive Care MedicineGastroenterologylaw.inventionSepsisRandomized controlled triallawInternal medicineSepsisSeptic shockRisk of mortalitymedicineClinical significanceMortalitybusiness.industrySeptic shockRC86-88.9ResearchMedical emergencies. Critical care. Intensive care. First aidVenous bloodmedicine.diseaseIgM ImmunoglobulinsbusinessIgA; IgG; IgM Immunoglobulins; Mortality; Sepsis; Septic shockIgM ImmunoglobulinIgACohort study
researchProduct

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

2017

Abstracts Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.

medicine.medical_specialtySepsiInvasive candidiasiCritical Care and Intensive Care MedicineProcalcitoninSepsis03 medical and health sciences0302 clinical medicineAntibiotic therapySepsismedicine030212 general & internal medicineIntensive care medicineLetter to the EditorCandida spp.Surrogate endpointbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicineInvasive candidiasislcsh:RC86-88.9medicine.diseasebacterial infections and mycosesCandida spp.; Invasive candidiasis; Procalcitonin; Sepsis; Critical Care and Intensive Care MedicinePredictive valueInvasive candidiasisCandida sppbusinessProcalcitoninhormones hormone substitutes and hormone antagonistsJournal of Intensive Care
researchProduct

Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial

2021

Abstract Background The best fluid replacement strategy and the role of albumin in immunocompromised patients with sepsis is unclear. Methods We performed a secondary analysis of immunocompromised patients enrolled in the ALBIOS trial which randomized patients with severe sepsis or septic shock to receive either 20% albumin (target 30 g per liter or more) and crystalloid or crystalloid alone during ICU stay. Results Of 1818 patients originally enrolled, 304 (16.4%) were immunocompromised. One-hundred-thirty-nine (45.7%) patients were randomized in the albumin while 165 (54.2%) in the crystalloid group. At 90 days, 69 (49.6%) in the albumin group and 89 (53.9%) in the crystalloids group died…

medicine.medical_specialtySepsimedicine.medical_treatmentSocio-culturaleCritical Care and Intensive Care MedicineSepsisAlbumin; Immunocompromised; Immunodeficiency; Sepsis; Septic shock03 medical and health sciencesImmunocompromised Host0302 clinical medicineInternal medicineSepsisAlbuminsSeptic shockmedicineHumansImmunodeficiencyRenal replacement therapyAlbumin; Immunocompromised; Immunodeficiency; Sepsis; Septic shock; Albumins; Crystalloid Solutions; Fluid Therapy; Humans; Immunocompromised Host; Sepsis; Shock SepticImmunocompromisedMechanical ventilationSeptic shockbusiness.industrySepticAlbuminHazard ratioAcute kidney injuryAlbumin030208 emergency & critical care medicineShockCrystalloid Solutionsmedicine.diseaseShock Septic030228 respiratory systemFluid TherapySOFA scorebusiness
researchProduct

miRNA-23b as a biomarker of culture-positive neonatal sepsis

2020

Abstract Background Neonatal sepsis remains an important cause of morbidity and mortality. The ability to quickly and accurately diagnose neonatal sepsis based on clinical assessments and laboratory blood tests remains difficult, where haemoculture is the gold standard for detecting bacterial sepsis in blood culture. It is also very difficult to study because neonatal samples are lacking. Methods Forty-eight newborns suspected of sepsis admitted to the Neonatology Department of the Mother-Child Specialized Hospital of Tlemcen. From each newborn, a minimum of 1–2 ml of blood was drawn by standard sterile procedures for blood culture. The miRNA-23b level in haemoculture was evaluated by RT-qP…

medicine.medical_specialtyShort ReportEarly-onset sepsisGastroenterologylcsh:BiochemistrySepsisInternal medicinemicroRNAGeneticsmedicinelcsh:QD415-436Blood cultureNeonatologyMolecular BiologyGenetics (clinical)miR-23bNewbornsHaemocultureNeonatal sepsismedicine.diagnostic_testbusiness.industrylcsh:RM1-950Gold standardLate-onset sepsismedicine.diseaseMolecular medicinelcsh:Therapeutics. PharmacologyMolecular MedicineBiomarker (medicine)businessMolecular Medicine
researchProduct

Association between elastic and muscular artery stiffness and organ dysfunction in patients with early severe sepsis

2015

Sepsis is characterised by massive inflammatory response, which can affect vascular function. As part of vascular dysfunction large arteries can be affected. To what extent changes in large artery function contribute to organ dysfunction in sepsis is not well studied.

medicine.medical_specialtybusiness.industryInflammatory responsefungiOrgan dysfunctionfood and beveragesLarge arteryCritical Care and Intensive Care Medicinemedicine.diseaseSurgerySepsisInternal medicinePoster PresentationmedicineMuscular arteryCardiologyIn patientmedicine.symptombusinessVascular functionSevere sepsisIntensive Care Medicine Experimental
researchProduct

Evaluation of automated hematologic VCS parameters in severe sepsis and septic shock: a case-control study.

2010

A cheap and quick hematologic diagnostic parameter for detection of sepsis would have both economic and therapeutic benefits. The Coulter LH series hematology analyzer uses the VCS technology (Volume, Conductivity, Laser Scatter) providing information about cell volume, size, internal structure, and surface morphology. Many authors analyzed the clinical usefulness of VCS parameters in reactive neutrophils for detection of sepsis. An increase in mean cell volume and a decrease in mean light scatter in septic patients have been described. Our aim is to verify the correlation between VCS parameters and sepsis.

medicine.medical_specialtybusiness.industrySeptic shockCell volumeSevere SepsiCase-control studySettore MED/41 - AnestesiologiaCritical Care and Intensive Care Medicinemedicine.diseaseSepsisSeptic ShockHematology analyzerInternal medicinePoster PresentationmedicineCardiologyVCSIntensive care medicinebusinessSevere sepsis
researchProduct

Use of Thromboelastography in severe sepsis a case-control Study

2011

Thromboelastography (TEG) is a global test of coagulation that records the viscoelastic changes in blood during clot formation. Cardiosurgery and liver transplantation are established fields of application for TEG. Severe sepsis is often characterized by an imbalance of the haemostatic equilibrium between clot formation and fibrinolysis in favor of a procoagulant status, especially in the first phase. A hypocoagulant status due to coagulation factor consumption could occur later. In spite of this, the correlation between TEG and sepsis is not clearly established. Moreover, there are doubts about which TEG-detected variable is best correlated with sepsis. The aim of this study is to clarify …

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentCase-control studyThromboelastography Severe Sepsis Septic ShockSettore MED/41 - AnestesiologiaLiver transplantationCritical Care and Intensive Care Medicinemedicine.diseaseClot formationThromboelastographySurgerySepsisCoagulationInternal medicineFibrinolysisPoster PresentationmedicineCardiologybusinessSevere sepsis
researchProduct

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers

2021

Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compared to those with normal immunoglobulin levels and, therefore, there is a rational explanation to administer intravenous IgM-enriched immunoglobulins to septic patients in ICU. Aim of this study is to evaluate the effectiveness of intravenous IgM-enriched immunoglobulins in decreasing several sepsis biomarker concentrations. 26 sepsis patients were enrolled in this observational cohort study and Nitric Oxide, Endocan, Pentraxin and presepsin serum levels were measured during their first 3 days of ICU stay. The use of intravenous IgM-enriched immunoglobulins did not influence the temporal evol…

medicine.medical_specialtysepsis - diagnosticsPopulationseptic shock (MeSH)presepsin (soluble CD14-subtype)RM1-950elderlyGastroenterologyNitric oxideSepsischemistry.chemical_compoundInternal medicineimmunoglobulin MmedicinePharmacology (medical)educationPharmacologyeducation.field_of_studybiologybusiness.industrySeptic shockBrief Research Reportmedicine.diseaseelderly; immunoglobulin M; presepsin (soluble CD14-subtype); sepsis - diagnostics; septic shock (MeSH)chemistryImmunoglobulin Mbiology.proteinBiomarker (medicine)Therapeutics. PharmacologyAntibodybusinessCohort studyFrontiers in Pharmacology
researchProduct